Co-Diagnostics, Inc.

NasdaqCM:CODX Stock Report

Market Cap: US$23.3m

Co-Diagnostics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Dwight Egan

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage29.7%
CEO tenure11.7yrs
CEO ownership1.6%
Management average tenureless than a year
Board average tenure4yrs

Recent management updates

Recent updates

Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

Jun 14
Here's Why We're Watching Co-Diagnostics' (NASDAQ:CODX) Cash Burn Situation

One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

May 18
One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%

A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Apr 14
A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Hold Thesis Remains Well Intact

Sep 07

Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes

Aug 11

Co-Diagnostics spikes on shipments of monkeypox test

Jul 11

Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Jul 06
Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)

Co-Diagnostics: Well Priced, Long-Term Value Remains Too Distant

Jun 21

Co-Diagnostics: Where's Eikon?

Apr 03

Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Mar 28
Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate

Co-Diagnostics: Swinging For The Fences

Jan 24

Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Dec 28
Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?

Why Co-Diagnostics Is A Solid Covid-19 Play

Aug 19

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

Aug 14
Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too

CEO Compensation Analysis

How has Dwight Egan's remuneration changed compared to Co-Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$41m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$39m

Dec 31 2023US$1mUS$375k

-US$35m

Sep 30 2023n/an/a

-US$43m

Jun 30 2023n/an/a

-US$38m

Mar 31 2023n/an/a

-US$32m

Dec 31 2022US$2mUS$366k

-US$14m

Sep 30 2022n/an/a

US$15m

Jun 30 2022n/an/a

US$28m

Mar 31 2022n/an/a

US$40m

Dec 31 2021US$2mUS$350k

US$37m

Sep 30 2021n/an/a

US$42m

Jun 30 2021n/an/a

US$46m

Mar 31 2021n/an/a

US$51m

Dec 31 2020US$1mUS$309k

US$42m

Sep 30 2020n/an/a

US$28m

Jun 30 2020n/an/a

US$10m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$460kUS$275k

-US$6m

Sep 30 2019n/an/a

-US$6m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$474kUS$275k

-US$6m

Sep 30 2018n/an/a

-US$6m

Jun 30 2018n/an/a

-US$8m

Mar 31 2018n/an/a

-US$8m

Dec 31 2017US$210kUS$195k

-US$7m

Compensation vs Market: Dwight's total compensation ($USD1.26M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Dwight's compensation has been consistent with company performance over the past year.

CEO

Dwight Egan (71 yo)

11.7yrs

Tenure

US$1,261,300

Compensation

Mr. Dwight H. Egan serves as the Chairman & Chief Executive Officer and was President at Co-Diagnostics, Inc. and has been its Director since April 2013. Mr. Egan has been engaged in private investment bus...

Leadership Team

NamePositionTenureCompensationOwnership
Dwight Egan
Chairman & CEOno dataUS$1.26m1.64%
$ 381.7k
Brian Brown
CFO & Company Secretary3.8yrsUS$1.04m1.32%
$ 306.5k
Richard Abbott
Presidentless than a yearno data1.89%
$ 441.5k
Brent Satterfield
Co-Founder & Member of Scientific Advisory Board11.7yrsUS$237.50kno data
David Nielsen
Chief Operating Officerless than a yearno datano data
Dan Bohrer
Vice President of Finance & Accountingno datano datano data
Christopher Thurston
Chief Technology Officerless than a yearno datano data
Andrew Benson
Head of Investor Relationsno datano datano data
Mayuranki Almaula
Senior Vice President of Overseas Operations & Strategic Alliancesno datano datano data
Cameron Gundry
Head of Commercialization LATAM/EURno datano datano data
Seth Egan
Chief Commercialization Officerless than a yearno datano data

0.7yrs

Average Tenure

50yo

Average Age

Experienced Management: CODX's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Dwight Egan
Chairman & CEO11.7yrsUS$1.26m1.64%
$ 381.7k
Brent Satterfield
Co-Founder & Member of Scientific Advisory Board2.8yrsUS$237.50kno data
Richard Serbin
Independent Director7.6yrsUS$298.00k0.52%
$ 121.1k
Carl Wittwer
Chairman of Scientific Advisory Board2.8yrsno datano data
James Nelson
Independent Director5.3yrsUS$298.00k0.51%
$ 119.2k
Noriko Kusukawa
Member of Scientific Advisory Board2.8yrsno datano data
Edward Murphy
Independent Director5.5yrsUS$298.00k0.55%
$ 128.4k
Eugene Durenard
Independent Director5.5yrsUS$298.00k0.51%
$ 119.2k
Karen Carroll
Member of Scientific Advisory Board2.8yrsno datano data
Anne Wyllie
Member of Scientific Advisory Board2.8yrsno datano data

4.0yrs

Average Tenure

59yo

Average Age

Experienced Board: CODX's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 19:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Co-Diagnostics, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi ChenH.C. Wainwright & Co.
James SidotiSidoti & Company, LLC